Qingdao Xingsai Biotechnology
A developer of single-cell analysis instruments and supporting reagents and consumables.
Launch date
Employees
Market cap
-
Enterprise valuation
$55—83m (Dealroom.co estimates Dec 2023.)
Qingdao Shandong (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Seed | |
* | CNY100m | Series A | |
* | N/A | Early VC | |
| Total Funding | $13.8m | ||